DE | Accessible presentation
Translations are powered by AI

The most important investments of the third quarter of 2024

Helsing, Egym, Catalym – many Munich-based startups successfully raised funding in the third quarter of this year. This photo gallery provides an overview of the largest investments in the third quarter of 2024.

October 8, 2024 4 min reading time

Catalym
Series D financing for Catalym: The biotech startup Catalym successfully completes its Series D financing round of 138 million euros. The oversubscribed financing round was led by new investors Canaan Partners and Bioqube Ventures, and joined by Forbion's Growth Opportunities Fund, Omega Funds, and Gilde Healthcare. Existing investors Jeito Capital, Brandon Capital Partners, Novartis Venture Fund, and Vesalius Biocapital III also participated in the round. The fresh capital will finance the Phase 2b development of visugromab for the treatment of various cancers.
read more ↓